Clinical Reflections®: Reflecting on Errors and Missed Opportunities in Chronic Urticaria

Program Overview

Chronic urticaria (CU), also referred to as chronic idiopathic urticaria or chronic spontaneous urticaria is an intensely-pruritic inflammatory skin disorder. Chronic urticaria can last from 6 weeks to several years, and often has a profound negative impact on patients’ quality of life. Chronic urticaria is often considered a notoriously difficult condition to treat. Treatment decisions can be clouded by confusion amongst clinicians regarding evidenced-based treatment guidelines, excessive reliance on personal experience and anecdotal information, and lack of familiarity or comfort with newer therapeutic options.

Credit Expired
CE Credit Expired
Expires: January 31, 2020

Target Audience

This activity is designed for the educational needs of US-based allergy/immunology and dermatology clinicians.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Recognize physical exam findings and symptomatology suggestive of chronic urticaria (CU) and appropriately apply evidence-based practices regarding diagnostic testing and laboratory workup
  • Utilize a guideline-driven approach to treatment intensification for safe and effective management of patients with CU in need of second- and third-line treatment options, while taking into account quality of life issues

Activity Faculty

Michael E. Manning, MD, FAAAAI, FACAAI

President/Medical Director
Medical Research of Arizona
Allergy, Asthma and Immunology Associates, Ltd.
Scottsdale, AZ

Anne Marie Ditto, MD

Associate Professor, Medicine
Division of Allergy-Immunology
Northwestern University
Feinberg School of Medicine
Chicago, IL

Supporter Statement

Provider Statement

Disclosure of Financial Relationships

Faculty

Planners and Managers

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources